The Nanoscale Fast-Act is a rapid response safety kit offering one-step neutralisation of either liquid or vapour spills. Fast-Act (First Applied Sorbent Treatment — Against Chemical Threats) has been successfully trialled on hydrofluoric acid at the Australian National University to complement its successful use on most toxic industrial chemicals and materials.
The laboratory kit helps neutralise toxic chemical incidents rapidly (liquid or vapour), facilitating rescues where these are needed and reducing the need for total evacuations.
The kit’s wall-mounted unit can be tailored to user requirements, employing 70, 300, 500 g, 3 and 5 kg shaker tubs of the product and 1, 2 and 4 kg fire extinguisher-style pressurised cylinders for liquids, vapour and off-gassing.
The technology behind Fast-Act results in a massive increase in the powder’s active surface area, which enables relatively small quantities of product to be used immediately on toxic liquid or vapour incidents.
The shaker tubs and pressure cylinders work very well in situations most likely to be encountered in laboratories, including spills in confined spaces and vapours around fume cupboards.
The product has broad applicability for situations where there is no way of knowing immediately what chemical is involved. It reacts with a wide range of acids, halogenated compounds, phosphorus compounds and organic compounds and so reduces the need to have multiple spill kits.
Fast-Act is supplied in extinguisher-style pressurised cylinders that are easy to operate and do not require any special training for users. Shaker bottles and pails are also available in a variety of sizes to best suit particular application requirements.
Phone: 02 8536 4000
Lumiprobe DusQ fluorescence quenchers
Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...
Enzo Life Sciences SCREEN-WELL Epigenetics library
Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...
LSBio PathPlus Cancer Antibodies
The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...